Document is current
Any future updates will be listed below
-
Authors
Mori, Yosai
Minami, Keiichiro https://orcid.org/0000-0002-9799-8342
Tokuda, Shota
Lee, Jinhee
Miyata, Kazunori
- License Information
-
More Information
Article History
Received: 10 June 2019
Accepted: 8 December 2019
First Online: 20 December 2019
Competing interests
: Dr. Mori received honorarium for lecturing from Alcon Japan Ltd., HOYA corporation, Japan, and Senju Pharmaceutical Co Ltd., Japan. Mr. Minami has consulted for AMO Japan K.K, Japan and Alcon Japan Ltd., and is one of investigators of a patent pending from Tomey Corporation, Japan. Dr. Miyata has been funded by AMO Japan K.K, Alcon Japan Ltd., HOYA corporation, Ohtsuka Pharmaceutical Co Ltd, Japan, Senju Pharmaceutical Co Ltd., Japan, and Santen Pharmaceutical Co Ltd., Japan. He has received honorarium for lecturing from AMO Japan K.K, Alcon Japan Ltd, HOYA corporation, Ohtsuka Pharmaceutical Co Ltd., Senju Pharmaceutical Co Ltd., Santen Pharmaceutical Co Ltd., and Chuo Sangio, and is one of investigators of a patent pending from Tomey Corporation. Mr. Tokunaga and Dr. Lee have no financial disclosures.
